Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-26-059373
Filing Date
2026-08-28
Accepted
2026-08-28 15:35:50
Documents
17
Period of Report
2026-08-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A csbr-20260828.htm   iXBRL DEF 14A 764565
6 csbr-20260828_g1.jpg GRAPHIC 102236
7 csbr-20260828_g2.jpg GRAPHIC 95588
8 csbr-20260828_g3.jpg GRAPHIC 5043
  Complete submission text file 0001628280-26-059373.txt   1951171

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20260828.xsd EX-101.SCH 2965
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20260828_def.xml EX-101.DEF 4073
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20260828_lab.xml EX-101.LAB 4431
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20260828_pre.xml EX-101.PRE 2803
20 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20260828_htm.xml XML 146106
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 001-11504 | Film No.: 261339396
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)